The objective was to examine gender differences in causes of death using the San Francisco HIV/AIDS and death registries. Data from San Francisco residents diagnosed with HIV/AIDS who died from 1996 to 2013 were analyzed. Age, race/ethnicity, year, and gender-adjusted standardized mortality ratios and Poisson 95% confidence intervals were calculated for underlying causes of death. Among the 6268 deaths, deaths attributed to drug use, mental disorders due to substance use, cerebrovascular disease, chronic obstructive pulmonary disease, renal disease, and septicemia were more likely among women than among men. Compared to the California population, women had elevated standardized mortality ratios for drug overdose (25.37), mental disorders due to substance abuse (27.21), cerebrovascular disease (2.83), chronic obstructive pulmonary disease (7.37), heart disease (2.37), and liver disease (5.54), and these were higher than the standardized mortality ratios for the men in our study. Men, but not women, had elevated standardized mortality ratios for suicide (2.70), undetermined intent (3.88), renal disease (2.29), and non-AIDS cancer (1.68) compared to population rates. Continued efforts to reduce HIV-related illnesses and an increased emphasis on diagnosing and treating preventable causes of death, including substance use, heart disease, and mental health disorders, are needed as part of comprehensive HIV care.
PalellaFDelaneyKMoormanAet al.Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med1998; 338: 853–860.
2.
SiddiqiAEHallHIHuXet al.Population-based estimates of life expectancy after HIV diagnosis: United States 2008–2011. J Acquir Immune Defic Syndr2016; 72: 230–236.
3.
SamjiHCesconAHoggRSet al.Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One2013; 8: e81355–e81355.
4.
FrenchALGawelSHHershowRet al.Trends in mortality and causes of death among women with HIV in the United States: a 10-year study. J Acquir Immune Defic Syndr2009; 51: 399–406.
5.
LewdenCSalmonDMorlatPet al.Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol2005; 34: 121–130.
6.
SackoffJEHannaDBPfeifferMRet al.Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med2006; 145: 397–406.
7.
CrumNFRiffenburghRHWegnerSet al.Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr2006; 41: 194–200.
8.
SmitCGeskusRWalkerSet al.Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS2006; 20: 741–749.
9.
SchwarczSKVuAHsuLCet al.Changes in causes of death among persons with AIDS: San Francisco, California, 1996–2011. AIDS Patient Care STDS2014; 28: 517–523.
10.
Centers for Disease Control and Prevention. HIV surveillance report, 2013, Atlanta: Centers for Disease Control and Prevention, 2015.
11.
HarrellE. Black victims of violent crime, Washington, DC: U.S. Dept. of Justice, Office of Justice Programs, Bureau of Justice Statistics, 2007.
12.
BreidingMJSmithSGBasileKCet al.Prevalence and characteristics of sexual violence, stalking, and intimate partner violence victimization – national intimate partner and sexual violence survey, United States, 2011. MMWR Surveill Summ2014; 63: 1–18.
13.
BarnesDMKeyesKMBatesLM. Racial differences in depression in the United States: how do subgroup analyses inform a paradox?Soc Psychiatry Psychiatr Epidemiol2013; 48: 1941–1949.
14.
Clements-NolleKMarxRGuzmanRet al.HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention. Am J Public Health2001; 91: 915–921.
15.
GavinARWaltonEChaeDHet al.The associations between socio-economic status and major depressive disorder among Blacks, Latinos, Asians and non-Hispanic Whites: findings from the Collaborative Psychiatric Epidemiology Studies. Psychol Med2010; 40: 51–61.
16.
HasinDSGoodwinRDStinsonFSet al.Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry2005; 62: 1097–1106.
17.
KesslerRCBerglundPDemlerOet al.The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA2003; 289: 3095–3105.
18.
MarshallEClaesLBoumanWPet al.Non-suicidal self-injury and suicidality in trans people: a systematic review of the literature. Int Rev Psychiatry2016; 28: 58–69.
19.
MillsTCPaulJStallRet al.Distress and depression in men who have sex with men: the Urban Men’s Health Study. Am J Psychiatry2004; 161: 278–285.
20.
MustanskiBAndrewsRHerrickAet al.A syndemic of psychosocial health disparities and associations with risk for attempting suicide among young sexual minority men. Am J Public Health2014; 104: 287–294.
21.
NuttbrockLBocktingWRosenblumAet al.Gender abuse, depressive symptoms, and HIV and other sexually transmitted infections among male-to-female transgender persons: a three-year prospective study. Am J Public Health2013; 103: 300–307.
22.
StrutzKLHerringAHHalpernCT. Health disparities among young adult sexual minorities in the U.S. Am J Prev Med2015; 48: 76–88.
23.
CooperHFriedmanSRTempalskiBet al.Racial/ethnic disparities in injection drug use in large US metropolitan areas. Ann Epidemiol2005; 15: 326–334.
24.
CooperHLBradyJEFriedmanSRet al.Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992–2002): estimation methods and prevalence trends. J Urban Health2008; 85: 826–856.
25.
HuebnerDMRebchookGMKegelesSM. Experiences of harassment, discrimination, and physical violence among young gay and bisexual men. Am J Public Health2004; 94: 1200–1203.
26.
KerrDDingKBurkeAet al.An alcohol, tobacco, and other drug use comparison of lesbian, bisexual, and heterosexual undergraduate women. Subst Use Misuse2015; 50: 340–349.
27.
KoblinBATorianLXuGet al.Violence and HIV-related risk among young men who have sex with men. AIDS Care2006; 18: 961–967.
28.
Morales-AlemanMMHagemanKGaulZJet al.Intimate partner violence and human immunodeficiency virus risk among black and Hispanic women. Am J Prev Med2014; 47: 689–702.
29.
RothmanEFExnerDBaughmanAL. The prevalence of sexual assault against people who identify as gay, lesbian, or bisexual in the United States: a systematic review. Trauma Violence Abuse2011; 12: 55–66.
30.
TjadenPThoennesNAllisonCJ. Comparing violence over the life span in samples of same-sex and opposite-sex cohabitants. Violence Vict1999; 14: 413–425.
31.
WilcoxHCConnerKRCaineED. Association of alcohol and drug use disorders and completed suicide: an empirical review of cohort studies. Drug Alcohol Depend2004; 76: S11–S19.
32.
WilsonECSantosGMRaymondHF. Sexual mixing and the risk environment of sexually active transgender women: data from a respondent-driven sampling study of HIV risk among transwomen in San Francisco, 2010. BMC Infect Dis2014; 14: 430–430.
33.
MdodoRFrazierELDubeSRet al.Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med2015; 162: 335–344.
34.
BorgesGWaltersEEKesslerRC. Associations of substance use, abuse, and dependence with subsequent suicidal behavior. Am J Epidemiol2000; 151: 781–789.
35.
van den Berk-ClarkCPatterson Silver WolfD. Mental health help seeking among traumatized individuals: a systematic review of studies assessing the role of substance use and abuse. Trauma Violence Abuse2017; 18: 106–116.
36.
MeyerJPSpringerSAAlticeFL. Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Womens Health (Larchmt)2011; 20: 991–1006.
37.
SullivanKAMesserLCQuinlivanEB. Substance abuse, violence, and HIV/AIDS (SAVA) syndemic effects on viral suppression among HIV positive women of color. AIDS Patient Care STDS2015; 29: S42–S48.
38.
XuJQMurphySLKochanekKDet al.Deaths: final data for 2013. Natl Vital Stat Rep2016; 64: 1–119.
39.
WeberAEHoggRS. Morbidity and mortality related to human immunodeficiency virus in Canadian men and women, 1987–94. Can J Public Health1999; 90: 127–132.
40.
CohenMHFrenchALBenningLet al.Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med2002; 113: 91–98.
41.
EhrenKHertensteinCKummerleTet al.Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection2014; 42: 135–140.
42.
MorlatPRoussillonCHenardSet al.Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS2014; 28: 1181–1191.
43.
HessolNAKalinowskiABenningLet al.Mortality among participants in the multicenter AIDS cohort study and the women’s interagency HIV study. Clin Infect Dis2007; 44: 287–294.
44.
LewdenCMayTRosenthalEet al.Changes in causes of death among adults infected by HIV between 2000 and 2005: the “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr2008; 48: 590–598.
45.
HannaDBRamaswamyCKaplanRCet al.Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001–2012. Clin Infect Dis2016; 63: 1122–1129.
46.
Antiretroviral Therapy Cohort Collaboration (ART-CC). Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US. Antivir Ther 2015; 20: 21–28.
47.
San Francisco Department of Public Health. HIV/AIDS epidemiology annual report 2013, San Francisco: HIV Epidemiology Section, San Francisco Department of Public Health AIDS Office, 2014.
48.
Department of Health and Human Services. Physician’s handbook on medical certification of death, DHHS Publication No: (PHS) 2003-1108. Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2003.
49.
Centers for Disease Control and Prevention. International classification of diseases. 9th revision. Hyattsville, MD: National Center for Health Statistics, 1979.
50.
Centers for Disease Control and Prevention. International classification of diseases. 10th revision. Hyattsville, MD: National Center for Health Statistics, 1999, 2013.
51.
National Center for Health Statistics. National death index user’s guide; Appendix B, Hyattsville, MD: National Center for Health Statistics, 2013.
52.
U.S. Census Bureau. 2006–2010 American Community Survey: Selected Economic Characteristics. US: U.S. Department of Commerce, 2013.
53.
State of California, Department of Finance. Race/Hispanics population with age and gender detail, 2000–2010, Sacramento, CA: Department of Finance, 2012.
54.
State of California. Department of Finance. Race/Ethnic population with age and sex detail, 1990–1999, Sacramento, CA: Department of Finance, 2009.
55.
SAS Institute, Inc. SAS/STAT user's guide, version 9.4, Cary, NC: SAS Institute, Inc, 2014.
56.
CimaMParkerRDAhmedYet al.Cause of death in HIV-infected patients in South Carolina (2005–2013). Int J STD AIDS2016; 27: 25–32.
57.
BreidingMJWiersemaB. Variability of undetermined manner of death classification in the US. Inj Prev2006; 12: ii49–ii54.
58.
BostwickWBBoydCJHughesTLet al.Discrimination and mental health among lesbian, gay, and bisexual adults in the United States. Am J Orthopsychiatry2014; 84: 35–45.
59.
NuttbrockLHwahngSBocktingWet al.Psychiatric impact of gender-related abuse across the life course of male-to-female transgender persons. J Sex Res2010; 47: 12–23.
60.
AnagnostopoulosALedergerberBJaccardRet al.Frequency of and risk factors for depression among participants in the Swiss HIV Cohort Study (SHCS). PLoS One2015; 10: e0140943–e0140943.
61.
CieslaJARobertsJE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry2001; 158: 725–730.
62.
RabkinJG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep2008; 5: 163–171.
63.
MorrisonMFPetittoJMTen HaveTet al.Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry2002; 159: 789–796.
64.
GrayGBergerP. Pain in women with HIV/AIDS. Pain2007; 132: S13–S21.
65.
KrashinDLMerrillJOTrescotAM. Opioids in the management of HIV-related pain. Pain Physician2012; 15: ES157–ES168.
66.
SiemieniukRAKrentzHBGillMJ. Intimate partner violence and HIV: a review. Curr HIV/AIDS Rep2013; 10: 380–389.
67.
MachtingerELWilsonTCHabererJEet al.Psychological trauma and PTSD in HIV-positive women: a meta-analysis. AIDS Behav2012; 16: 2091–2100.
68.
BrezingCFerraraMFreudenreichO. The syndemic illness of HIV and trauma: implications for a trauma-informed model of care. Psychosomatics2015; 56: 107–118.
69.
GrantBF. Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse1995; 7: 481–497.
70.
ManchikantiLCashKADamronKSet al.Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables. Pain Physician2006; 9: 215–225.
71.
CokerALDavisKEAriasIet al.Physical and mental health effects of intimate partner violence for men and women. Am J Prev Med2002; 23: 260–268.
72.
KesslerRCSonnegaABrometEet al.Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry1995; 52: 1048–1060.
73.
LifsonARLandoHA. Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep2012; 9: 223–230.
74.
Centers for Disease Control and Prevention. Current cigarette smoking among adults – United States, 2005–2014. Morb Mortal Wkly Rep2015; 64: 1233–1240.
75.
Centers for Disease Control and Prevention. State tobacco activities tracking & evaluation (STATE) system. Map of current cigarette use among adults (behavior risk factor surveillance system), https://www.cdc.gov/statesystem/cigaretteuseadult.html (2014, accessed 7 July 2017).
76.
HaimDYLippmannMLGoldbergSKet al.The pulmonary complications of crack cocaine. A comprehensive review. Chest1995; 107: 233–240.
77.
LeecePRajaramNWoolhouseSet al.Acute and chronic respiratory symptoms among primary care patients who smoke crack cocaine. J Urban Health2013; 90: 542–551.
78.
SilverbergMJLauBJusticeACet al.Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis2012; 54: 1026–1034–1026–1034.
79.
WormSWBowerMReissPet al.Non-AIDS defining cancers in the D:A:D study – time trends and predictors of survival: a cohort study. BMC Infect Dis2013; 13: 471–471.
80.
TrepkaMJSheehanDMFennieKPet al.Completeness of HIV reporting on death certificates for Floridians reported with HIV infection, 2000–2011. AIDS Care2016; 28: 98–103.
81.
MaltaMStrathdeeSAMagnaniniMMet al.Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction2008; 103: 1242–1257.
82.
EnteenLBauerJMcLeanRet al.Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health2010; 87: 931–941.
83.
Substance Abuse and Mental Health Services Administration. SAMHSA’s concept of trauma and guidance for a trauma-informed approach. HHS publication no. (SMA) 14-4884. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.
84.
MachtingerELCucaYPKhannaNet al.From treatment to healing: the promise of trauma-informed primary care. Womens Health Issues2015; 25: 193–197.
85.
Patient Protection and Affordable Care Act. Pub. L. No. 111-148, §2702, 124 Stat. 119, 318–319, 2010.
86.
Commonwealth Fund; Henry J. Kaiser Family Foundation. Primary care providers’ views of recent trends in health care delivery and payment. Findings from the Commonwealth Fund/Kaiser Family Foundation 2015 national survey of primary care providers. Issue Brief (Commonw Fund)2015; 24: 1–13.
